Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Rex

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean-Ralph Zahar, Jeff Alder, et al.
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2023
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical NeedYuliya Yasinskaya, Shukal Bala, Ursula Waack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean-Ralph Zahar, Jeff Alder, et al.
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Pageof 10